
Quotient Clinical delivers breakthrough first-in-human program for Corcept Therapeutics
[wp_ad_camp_4]Quotient Clinical, the Translational Pharmaceutics® Company, has announced the successful completion of an Enabled-First-in-Human® (Enabled-FIH) program for US biotech company